AAPL335.21+5.81 (+1.76%) ▲|ABBV262.85-0.44 (-0.17%) ▼|ABT98.94-2.02 (-2.00%) ▼|ACN183.18+6.06 (+3.42%) ▲|ADBE240.42+7.25 (+3.11%) ▲|AMAT514.21+2.20 (+0.43%) ▲|AMD612.80+5.23 (+0.86%) ▲|AMGN422.03-1.61 (-0.38%) ▼|AMT163.99-1.57 (-0.95%) ▼|AMZN250.14+3.47 (+1.40%) ▲|AVGO351.88-3.22 (-0.91%) ▼|AXP304.26-1.15 (-0.37%) ▼|BA186.40-1.28 (-0.68%) ▼|BAC54.57-0.39 (-0.71%) ▼|BKNG162.83+0.49 (+0.30%) ▲|BLK1,060.33-7.61 (-0.71%) ▼|BMY62.84-0.03 (-0.04%) ▼|BNY145.10-1.89 (-1.28%) ▼|BRK-B498.80-3.55 (-0.71%) ▼|C129.99-0.81 (-0.62%) ▼|CAT813.14-13.50 (-1.63%) ▼|CL85.64-0.83 (-0.95%) ▼|CMCSA21.87+0.27 (+1.23%) ▲|COF193.92-2.55 (-1.30%) ▼|COP125.35-0.09 (-0.07%) ▼|COST912.33-12.26 (-1.33%) ▼|CRM229.72+4.41 (+1.96%) ▲|CSCO107.93+0.99 (+0.93%) ▲|CVS86.02-1.08 (-1.24%) ▼|CVX205.10+0.72 (+0.35%) ▲|DE673.61-5.27 (-0.78%) ▼|DHR222.09-3.62 (-1.60%) ▼|DIS105.55+0.14 (+0.13%) ▲|DUK114.29+0.08 (+0.07%) ▲|EMR155.66-1.58 (-1.00%) ▼|FDX285.48-1.99 (-0.69%) ▼|GD332.51+0.17 (+0.05%) ▲|GE313.80-4.09 (-1.29%) ▼|GEV950.93-11.56 (-1.20%) ▼|GILD149.35-1.93 (-1.28%) ▼|GM77.27-3.20 (-3.98%) ▼|GOOG338.84+1.52 (+0.45%) ▲|GOOGL341.74+0.82 (+0.24%) ▲|GS902.61-13.63 (-1.49%) ▼|HD284.50-3.54 (-1.23%) ▼|HON211.84+1.71 (+0.81%) ▲|IBM220.48+0.49 (+0.22%) ▲|INTC120.23+4.30 (+3.71%) ▲|INTU275.92+7.89 (+2.94%) ▲|ISRG407.28-4.91 (-1.19%) ▼|JNJ265.57-2.00 (-0.75%) ▼|JPM331.74-3.24 (-0.97%) ▼|KO86.24-0.60 (-0.69%) ▼|LIN476.59+3.22 (+0.68%) ▲|LLY1,165.13-19.50 (-1.65%) ▼|LMT509.85-2.36 (-0.46%) ▼|LOW185.01-2.25 (-1.20%) ▼|LRCX330.04+6.18 (+1.91%) ▲|MA553.44-10.15 (-1.80%) ▼|MCD231.37-2.61 (-1.12%) ▼|MDLZ57.92-0.89 (-1.51%) ▼|MDT86.70-0.39 (-0.45%) ▼|META727.07-11.72 (-1.59%) ▼|MMM164.91-3.58 (-2.12%) ▼|MO67.54-1.18 (-1.72%) ▼|MRK146.05-3.23 (-2.16%) ▼|MS188.89-3.88 (-2.01%) ▼|MSFT512.85+3.89 (+0.76%) ▲|MU1,063.07-2.01 (-0.19%) ▼|NEE76.04+0.15 (+0.20%) ▲|NFLX69.64-0.66 (-0.94%) ▼|NKE35.38-0.47 (-1.30%) ▼|NOW134.22+4.28 (+3.29%) ▲|NVDA229.46+2.25 (+0.99%) ▲|ORCL137.37-0.43 (-0.31%) ▼|PEP126.88-1.81 (-1.41%) ▼|PFE28.61-0.12 (-0.40%) ▼|PG145.73-2.59 (-1.75%) ▼|PLTR187.35+0.38 (+0.20%) ▲|PM192.07-1.84 (-0.95%) ▼|QCOM184.39+0.29 (+0.16%) ▲|RTX186.15-0.80 (-0.43%) ▼|SBUX93.96-1.47 (-1.54%) ▼|SCHW97.74-1.36 (-1.37%) ▼|SO82.92-0.53 (-0.64%) ▼|SPG200.65-3.63 (-1.78%) ▼|T24.44-0.04 (-0.16%) ▼|TMO678.39-1.22 (-0.18%) ▼|TMUS163.60+0.62 (+0.38%) ▲|TSLA354.14+1.30 (+0.37%) ▲|TXN280.09-1.60 (-0.57%) ▼|UBER68.51-0.85 (-1.23%) ▼|UNH367.31-7.63 (-2.04%) ▼|UNP272.11-2.04 (-0.74%) ▼|UPS93.43-0.50 (-0.53%) ▼|USB57.77+0.17 (+0.30%) ▲|V359.50-6.38 (-1.74%) ▼|VZ45.90-0.08 (-0.17%) ▼|WFC80.11-0.37 (-0.46%) ▼|WMT103.92-2.88 (-2.70%) ▼|XOM162.88+1.53 (+0.95%) ▲|AAPL335.21+5.81 (+1.76%) ▲|ABBV262.85-0.44 (-0.17%) ▼|ABT98.94-2.02 (-2.00%) ▼|ACN183.18+6.06 (+3.42%) ▲|ADBE240.42+7.25 (+3.11%) ▲|AMAT514.21+2.20 (+0.43%) ▲|AMD612.80+5.23 (+0.86%) ▲|AMGN422.03-1.61 (-0.38%) ▼|AMT163.99-1.57 (-0.95%) ▼|AMZN250.14+3.47 (+1.40%) ▲|AVGO351.88-3.22 (-0.91%) ▼|AXP304.26-1.15 (-0.37%) ▼|BA186.40-1.28 (-0.68%) ▼|BAC54.57-0.39 (-0.71%) ▼|BKNG162.83+0.49 (+0.30%) ▲|BLK1,060.33-7.61 (-0.71%) ▼|BMY62.84-0.03 (-0.04%) ▼|BNY145.10-1.89 (-1.28%) ▼|BRK-B498.80-3.55 (-0.71%) ▼|C129.99-0.81 (-0.62%) ▼|CAT813.14-13.50 (-1.63%) ▼|CL85.64-0.83 (-0.95%) ▼|CMCSA21.87+0.27 (+1.23%) ▲|COF193.92-2.55 (-1.30%) ▼|COP125.35-0.09 (-0.07%) ▼|COST912.33-12.26 (-1.33%) ▼|CRM229.72+4.41 (+1.96%) ▲|CSCO107.93+0.99 (+0.93%) ▲|CVS86.02-1.08 (-1.24%) ▼|CVX205.10+0.72 (+0.35%) ▲|DE673.61-5.27 (-0.78%) ▼|DHR222.09-3.62 (-1.60%) ▼|DIS105.55+0.14 (+0.13%) ▲|DUK114.29+0.08 (+0.07%) ▲|EMR155.66-1.58 (-1.00%) ▼|FDX285.48-1.99 (-0.69%) ▼|GD332.51+0.17 (+0.05%) ▲|GE313.80-4.09 (-1.29%) ▼|GEV950.93-11.56 (-1.20%) ▼|GILD149.35-1.93 (-1.28%) ▼|GM77.27-3.20 (-3.98%) ▼|GOOG338.84+1.52 (+0.45%) ▲|GOOGL341.74+0.82 (+0.24%) ▲|GS902.61-13.63 (-1.49%) ▼|HD284.50-3.54 (-1.23%) ▼|HON211.84+1.71 (+0.81%) ▲|IBM220.48+0.49 (+0.22%) ▲|INTC120.23+4.30 (+3.71%) ▲|INTU275.92+7.89 (+2.94%) ▲|ISRG407.28-4.91 (-1.19%) ▼|JNJ265.57-2.00 (-0.75%) ▼|JPM331.74-3.24 (-0.97%) ▼|KO86.24-0.60 (-0.69%) ▼|LIN476.59+3.22 (+0.68%) ▲|LLY1,165.13-19.50 (-1.65%) ▼|LMT509.85-2.36 (-0.46%) ▼|LOW185.01-2.25 (-1.20%) ▼|LRCX330.04+6.18 (+1.91%) ▲|MA553.44-10.15 (-1.80%) ▼|MCD231.37-2.61 (-1.12%) ▼|MDLZ57.92-0.89 (-1.51%) ▼|MDT86.70-0.39 (-0.45%) ▼|META727.07-11.72 (-1.59%) ▼|MMM164.91-3.58 (-2.12%) ▼|MO67.54-1.18 (-1.72%) ▼|MRK146.05-3.23 (-2.16%) ▼|MS188.89-3.88 (-2.01%) ▼|MSFT512.85+3.89 (+0.76%) ▲|MU1,063.07-2.01 (-0.19%) ▼|NEE76.04+0.15 (+0.20%) ▲|NFLX69.64-0.66 (-0.94%) ▼|NKE35.38-0.47 (-1.30%) ▼|NOW134.22+4.28 (+3.29%) ▲|NVDA229.46+2.25 (+0.99%) ▲|ORCL137.37-0.43 (-0.31%) ▼|PEP126.88-1.81 (-1.41%) ▼|PFE28.61-0.12 (-0.40%) ▼|PG145.73-2.59 (-1.75%) ▼|PLTR187.35+0.38 (+0.20%) ▲|PM192.07-1.84 (-0.95%) ▼|QCOM184.39+0.29 (+0.16%) ▲|RTX186.15-0.80 (-0.43%) ▼|SBUX93.96-1.47 (-1.54%) ▼|SCHW97.74-1.36 (-1.37%) ▼|SO82.92-0.53 (-0.64%) ▼|SPG200.65-3.63 (-1.78%) ▼|T24.44-0.04 (-0.16%) ▼|TMO678.39-1.22 (-0.18%) ▼|TMUS163.60+0.62 (+0.38%) ▲|TSLA354.14+1.30 (+0.37%) ▲|TXN280.09-1.60 (-0.57%) ▼|UBER68.51-0.85 (-1.23%) ▼|UNH367.31-7.63 (-2.04%) ▼|UNP272.11-2.04 (-0.74%) ▼|UPS93.43-0.50 (-0.53%) ▼|USB57.77+0.17 (+0.30%) ▲|V359.50-6.38 (-1.74%) ▼|VZ45.90-0.08 (-0.17%) ▼|WFC80.11-0.37 (-0.46%) ▼|WMT103.92-2.88 (-2.70%) ▼|XOM162.88+1.53 (+0.95%) ▲|
23.7 C
New York
Wednesday, September 30, 2026

Tag: information

newssourceFORcompanyinformationcontent1releasesmarket

Illimis Therapeutics Closes 58 billion KRW ($42 million) Series B Financing to accelerate CNS and Immune Disease Drug Development via GAIA Platform

Validates technological prowess of GAIA platform and intensifies global co-development effort, including the existing partnership with Lilly Catalyze360-ExploR&DFunds to accelerate Alzheimer's and immune disease...

LABASIA 2025 UNITES SOUTHEAST ASIA’S SCIENTIFIC COMMUNITY FOR A GREENER, SMARTER FUTURE

From AI breakthroughs to sustainable science, Southeast Asia's premier lab exhibition ignites global collaboration and next-gen solutions. KUALA LUMPUR, Malaysia, July 14, 2025 /PRNewswire/ --...

Power Metallic Closes on Li-FT Power Land Acquisition

TORONTO, July 14, 2025 /PRNewswire/ - Power Metallic Mines Inc. (the "Company" or "Power Metallic") (TSXV: PNPN) (OTCBB: PNPNF) (Frankfurt: IVV) Power Metallic is pleased to...

OMass Therapeutics Presents Positive Preclinical Data For its Best-in-class MC2 Program at ENDO 2025

PRESS RELEASE

Ellomay Capital Ltd. Announces a Proposed Private Placement of Ordinary Shares to Israeli Institutional and Classified Investors for Approximately NIS 50 Million

Tel-Aviv, Israel, July 14, 2025 (GLOBE NEWSWIRE) -- Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable energy and power projects in Europe, USA and Israel, today announced that it received and accepted, following the approval of its Board of Directors, commitments from several Israeli institutional and classified investors to buy 926,000 ordinary shares of the Company in a private placement (the “Private Placement”). As a result of the Private Placement, an affiliate of Menora Mivtachim Holdings Ltd. (one of Israel’s largest institutional investors), which holds securities for the benefit of members of provident funds or pension funds, is expected to become an interested party in the Company, holding approximately 6% of the Company’s outstanding shares.

Dulux Professional from AkzoNobel reaffirms its commitment to sustainability at the Singapore International Green Building Conference 2025 (IGBC-SG 2025)

SINGAPORE, July 14, 2025 /PRNewswire/ -- At the Singapore International Green Building Conference 2025 (IGBC-SG 2025), Dulux Professional from AkzoNobel introduces groundbreaking paints and...

Falcon Oil & Gas Ltd (“Falcon”) – Another Stellar IP60 Flow Test Result in the Beetaloo and 2025 Drilling Campaign Commences

Falcon Oil & Gas Ltd (“Falcon”)

The Bill Busters Launches Genesis Credit Restoration to Deliver Added Value to Customers

The Bill Busters Launches Genesis Credit Restoration, Offering Free Credit Repair to Customers Bundling Services Amid Rising Demand for Financial Wellness 
The Bill Busters Launches Genesis Credit Restoration, Offering Free Credit Repair to Customers Bundling Services Amid Rising Demand for Financial Wellness

Anavar for Women: Exploring the Rise of Anvarol Performance Supplement Among Female Bodybuilders and Athletes From CrazyBulk

Anavar for Women is trending in 2025 as fitness-focused women seek safer, effective cutting support. Discover how Anvarol is emerging as a leading legal alternative tailored for lean muscle tone, stamina, and strength—without synthetic risk. 
Anavar for Women is trending in 2025 as fitness-focused women seek safer, effective cutting support. Discover how Anvarol is emerging as a leading legal alternative tailored for lean muscle tone, stamina, and strength—without synthetic risk.

European Premium Meats From Poland – a Modern Choice for Korean Kitchens

SEOUL, South Korea, July 13, 2025 (GLOBE NEWSWIRE) -- Sometimes, the most remarkable culinary revolutions happen not with bold innovations, but with quiet refinements. As European premium meats enter Korean kitchens, they introduce new depths of purity, flavor, and responsibility to recipes long cherished.

DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Rockerbox Customers Whose Data May Have Been Compromised

The law firm of Edelson Lechtzin LLP is investigating data privacy claims regarding an incident at Rockerbox.

DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Artivion, Inc. Customers Whose Data May Have Been Compromised

Edelson Lechtzin LLP is investigating data privacy claims regarding an incident at Artivion, Inc.

OGN IMPORTANT DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Organon & Co. Investors with Losses in Excess of $100K to Secure Counsel Before Important...

NEW YORK, July 13, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Organon & Co. (NYSE: OGN) between November 3, 2022 and April 30, 2025, both dates inclusive (the “Class Period”), of the important July 22, 2025 lead plaintiff deadline.

Crinetics to Present New Long-Term Data Demonstrating Durable Control of Once-Daily, Oral PALSONIFY™ (Paltusotine) in Acromegaly at ENDO 2025

Data show that PALSONIFY was well tolerated and IGF-1 levels remained stably controlled during long-term open label extensions of PATHFNDR-1 and PATHFNDR-2 studies

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsInformation

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers